Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?
Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning. Investors are increasingly hearing how artificial intelligence may make drug develo…
Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning. Investors are increasingly hearing how artificial intelligence may make drug develo…